Panel discussion

The following questions are discussed (timestamps in parentheses):

• Given the increasing level of awareness in recent years, are things getting better or still getting worse? (00:23)
• Is it acceptable to not give the best available antibiotic therapy to patients today in order to preserve them for future generations? (02:41)
• Many consider themselves to neither have the time nor the money to wait out the body’s own immune system to heal a minor infection, such as ear infections or tonsillitis. What norms and values do we need to change in order to reduce further spread of resistance? (04:27)
• The pipeline of new antibiotics is almost running dry, but how much more can we really get out of the existing antibiotics? Is it time to move on to alternative drugs? (06:23)
• Are public-private partnerships the only way to spur development of badly needed new antibiotics or are there other ways to promote innovation financially? (09:18)
• How can one argue to spend money on antibiotic resistance in a low-income country with limited resources, where you have basic problems, such as lack of sanitation, clean water and education? (13:52)
• What are the most important action points right now? (19:00)
• Where will we be in 50 years? (21:58)